Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabre Insurance Group Regulatory News (SBRE)

Share Price Information for Sabre Insurance Group (SBRE)

Share Price is delayed by 15 minutes
Get Live Data
171.00    2.60 (1.54%)
Bid:
171.20
Ask:
171.80
Spread: 0.60 (0.35%)
Market Cap: £416.08m
SBRE Live PriceLast checked at - London Stock Exchange

Intraday Sabre Insurance Group Share Chart

Director/PDMR Shareholding Replacement

22 Apr 2021 10:00

RNS Number : 3067W
Sabre Insurance Group PLC
22 April 2021
Β 

22 April 2021

Β 

Sabre Insurance Group plc ("Sabre" or the "Company")

Notification of transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

Β 

Sabre announces that on 21 April 2021, the following Directors and PDMRs of the Company were each granted an option under the Sabre 2017 Sharesave Plan (the "Plan") over ordinary shares of Β£0.001 in the Company as detailed below:

Β 

Name

Position

No of shares subject to option

Option Price

Bonus Date

Geoff Carter

Chief Executive Officer

4,680

Β£1.923

1 July 2024

Trevor Webb

Claims Director

Β 

4,680

Β£1.923

1 July 2024

Adam Westwood

Chief Financial Officer

9,360

Β£1.923

1 July 2024

Matt Wright

Chief Actuary

4,680

Β 

Β£1.923

1 July 2024

Β 

Subject to the terms of the Plan, the options will vest on the Bonus Date and be exercisable for a period of six months, subject to continued service with the Company.

Β 

This notification is made pursuant to Article 19 of the EU Market Abuse Regulation.

Β 

Additional Information:

Anneka Kingan - Company Secretary

Anneka.kingan@sabre.co.ukΒ 

Β 

Β 

Β 

Β 

Β 

PDMR transaction notification

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Geoff Carter

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Chief Executive Officer

b)

Β 

Initial notification /Amendment

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Sabre Insurance Group Plc

b)

Β 

LEI

Β 

2138006RXRQ8P8VKGV98

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

A non-transferable option over ordinary shares in the Company under the Sabre 2017 Sharesave Plan ('the Option')

Identification code

GB00BYWVDP49

b)

Β 

Nature of the transaction

Β 

Grant of option

c)

Β 

Price(s) and volume(s)

Β 

Price per share

Volume

Β£1.923

4,680

d)

Aggregated Information

Volume

Price

Β 

Volume

Price per share

4,680

Β£1.923

Β 

e)

Date of transaction

21 April 2020

f)

Place of transaction

London Stock Exchange (XLON)

Β 

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Trevor Webb

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Claims Director

b)

Β 

Initial notification /Amendment

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Sabre Insurance Group Plc

b)

Β 

LEI

Β 

2138006RXRQ8P8VKGV98

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

A non-transferable option over ordinary shares in the Company under the Sabre 2017 Sharesave Plan ('the Option')

Identification code

GB00BYWVDP49

b)

Β 

Nature of the transaction

Β 

Grant of option

c)

Β 

Price(s) and volume(s)

Β 

Price per share

Volume

Β£1.923

4,680

d)

Aggregated Information

Volume

Price

Β 

Volume

Price per share

4,680

Β£1.923

Β 

e)

Date of transaction

21 April 2020

f)

Place of transaction

London Stock Exchange (XLON)

Β 

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Adam Westwood

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Chief Financial Officer

b)

Β 

Initial notification /Amendment

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Sabre Insurance Group Plc

b)

Β 

LEI

Β 

2138006RXRQ8P8VKGV98

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

A non-transferable option over ordinary shares in the Company under the Sabre 2017 Sharesave Plan ('the Option')

Identification code

GB00BYWVDP49

b)

Β 

Nature of the transaction

Β 

Grant of option

c)

Β 

Price(s) and volume(s)

Β 

Price per share

Volume

Β£1.923

9,360

d)

Aggregated Information

Volume

Price

Β 

Volume

Price per share

9,360

Β£1.923

Β 

e)

Date of transaction

21 April 2020

f)

Place of transaction

London Stock Exchange (XLON)

Β 

Β 

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Matt Wright

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Chief Actuary

b)

Β 

Initial notification /Amendment

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Sabre Insurance Group Plc

b)

Β 

LEI

Β 

2138006RXRQ8P8VKGV98

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

A non-transferable option over ordinary shares in the Company under the Sabre 2017 Sharesave Plan ('the Option')

Identification code

GB00BYWVDP49

b)

Β 

Nature of the transaction

Β 

Grant of option

c)

Β 

Price(s) and volume(s)

Β 

Price per share

Volume

Β£1.923

4,680

d)

Aggregated Information

Volume

Price

Β 

Volume

Price per share

4,680

Β£1.923

Β 

e)

Date of transaction

21 April 2020

f)

Place of transaction

London Stock Exchange (XLON)

Β 

Additional Information:

Anneka Kingan - Company Secretary

Anneka.kingan@sabre.co.ukΒ 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHKZGZDRZRGMZG
Date   Source Headline
11th May 20211:20 pmRNSDirector/PDMR Shareholding
22nd Apr 202110:00 amRNSDirector/PDMR Shareholding Replacement
22nd Apr 20219:51 amRNSDirector/PDMR Shareholding
14th Apr 20219:01 amRNSDirector/PDMR Shareholding
13th Apr 202111:12 amRNSDirector/PDMR Shareholding
12th Apr 20214:41 pmRNSNotice of AGM
7th Apr 20212:16 pmRNSDirector/PDMR Shareholding
30th Mar 20211:56 pmRNSDirector/PDMR Shareholding
26th Mar 20218:24 amRNSDirector/PDMR Shareholding
16th Mar 20217:03 amRNSFinal Results
12th Mar 20217:00 amRNSNotice of Results
11th Mar 202110:37 amRNSDirector/PDMR Shareholding
1st Mar 20213:56 pmRNSHolding(s) in Company
23rd Feb 202110:40 amRNSNotice of Results
11th Feb 202110:28 amRNSDirector/PDMR Shareholding
1st Feb 202110:02 amRNSHolding(s) in Company
12th Jan 202110:53 amRNSDirector/PDMR Shareholding
8th Jan 20219:44 amRNSHolding(s) in Company
11th Dec 20201:31 pmRNSDirector/PDMR Shareholding
3rd Dec 20207:56 amRNSHolding(s) in Company
3rd Dec 20207:00 amRNSBoard Appointment
27th Nov 20204:42 pmRNSSecond Price Monitoring Extn
27th Nov 20204:37 pmRNSPrice Monitoring Extension
11th Nov 202012:07 pmRNSDirector/PDMR Shareholding
6th Nov 202011:39 amRNSHolding(s) in Company
6th Nov 202010:55 amRNSHolding(s) in Company
27th Oct 20203:47 pmRNSDirector/PDMR Shareholding
15th Oct 20207:00 amRNSDirector/PDMR Shareholding
13th Oct 20209:42 amRNSDirector/PDMR Shareholding
13th Oct 20207:00 amRNSTrading Statement
11th Sep 202010:07 amRNSDirector/PDMR Shareholding
3rd Sep 20204:13 pmRNSDirector/PDMR Shareholding
1st Sep 20202:23 pmRNSDirector/PDMR Shareholding
28th Aug 202012:02 pmRNSPrice Monitoring Extension
27th Aug 202011:32 amRNSDirector/PDMR Shareholding
19th Aug 20207:00 amRNSDirectorate Change
12th Aug 20203:50 pmRNSHolding(s) in Company
11th Aug 20201:15 pmRNSDirector/PDMR Shareholding
10th Aug 20204:00 pmRNSHolding(s) in Company
6th Aug 202012:14 pmRNSDirector/PDMR Shareholding - Correction
6th Aug 202010:11 amRNSDirector/PDMR Shareholding
6th Aug 20209:32 amRNSDirector/PDMR Shareholding
3rd Aug 202012:54 pmRNSDirector/PDMR Shareholding
28th Jul 20207:02 amRNSBoard appointment
28th Jul 20207:00 amRNSHalf-year Report
14th Jul 20204:13 pmRNSHolding(s) in Company
13th Jul 202012:51 pmRNSDirector/PDMR Shareholding
30th Jun 20201:33 pmRNSDirector/PDMR Shareholding
11th Jun 20201:59 pmRNSDirector/PDMR Shareholding
10th Jun 20209:57 amRNSDirector/PDMR Shareholding - Correction

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.